Skip to main content

CASE REPORT article

Front. Psychiatry
Sec. Psychopharmacology
Volume 15 - 2024 | doi: 10.3389/fpsyt.2024.1502773
This article is part of the Research Topic Case Reports in Psychopharmacology, volume III View all articles

Pregabalin treatment in a 30-year-old patient with Bainbridge-Ropers syndrome: a case-report

Provisionally accepted
  • 1 Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
  • 2 Université de Lausanne, Lausanne, Vaud, Switzerland

The final, formatted version of the article will be published soon.

    Mr. X is a Swiss patient with Bainbridge-Ropers syndrome clinically and genetically diagnosed at the age of 28. He is also known to have severe intellectual disability, autism spectrum disorder and epilepsy since the age of 18. At the age of 30, he was admitted for the first time to a psychiatric crisis unit dedicated to mental disabilities for challenging behavior such as self-aggression (forceful vomiting, scratching himself, pulling out his toe and fingernails or banging his head against the wall), agitation, screaming, dropping to the ground, damaging electronic items, or even displaying heteroaggressive gestures (trying to bite or pull hair, scratching, kicking, or punching) associated with a drop in mood, withdrawal from usual activities, a drop in social interaction and a tendency to doze off during the day. The introduction of Pregabalin leads to rapid stabilization of the clinical state, almost complete improvement in challenging behavior and gradual withdrawal of other treatments (class 2 analgesics, neuroleptics, antidepressants, and benzodiazepines). At the neurological check-up 9 months after discharge from hospital, clinical stability was confirmed by the surrounding team and the medical observation, with almost complete disappearance of auto-aggressive gestures.

    Keywords: Bainbridge-Ropers syndrome, ASXL3, Pregabalin (PGB), autism, Anxiety, Epilepsy

    Received: 27 Sep 2024; Accepted: 15 Nov 2024.

    Copyright: © 2024 Geiser, Good and Guinchat. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Marie Geiser, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
    Vincent Guinchat, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.